XOMA Corporation
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pr…
Biotechnology
US, EmeryVille [HQ]
Strategy & Leadership
All directors and officers of XOMA Corporation are sourced directly from the SEC or manually.
For the SEC we either use the Form 3/4/5 or, even better extract the compensation for each leader out of the audited proxy statement (DEF-14A).
Each datapoint refers the most recent appearance of the corresponding person.
Officers & BofD Beta
For the SEC we either use the Form 3/4/5 or, even better extract the compensation for each leader out of the audited proxy statement (DEF-14A).
Total Compensation
Shows the total compensation per mentioned executive and board director.Each datapoint refers the most recent appearance of the corresponding person.
- No data, only available if we have DEF 14A compensations in place -
Officers
Name & Position | Research | Last Appearance | ||
---|---|---|---|---|
Sitko Bradley
Chief Investment Officer
|
01/10/25 [Form 4]
|
|||
Burns Thomas M.
SVP, Finance & CFO
|
11/13/24 [Form 4]
|
|||
Hughes Owen
Chief Executive Officer
Also inside the BofD
|
11/13/24 [Form 4]
|
|||
Neal James R
CEO
Also inside the BofD
|
07/18/22 [Form 4]
|
Board of Directors (BofD)
Name & Position | Research | Last Appearance | ||
---|---|---|---|---|
Wyszomierski Jack L
Director
|
05/17/24 [Form 4]
|
|||
Perry Matthew D
Director
|
05/17/24 [Form 4]
|
|||
Limber Joseph M
Director
|
05/17/24 [Form 4]
|
|||
Kosacz Barbara
Director
|
05/17/24 [Form 4]
|
|||
Hernday Natasha
Director
|
05/17/24 [Form 4]
|
|||
Franklin Heather L
Director
|
05/17/24 [Form 4]
|
|||
Van Ness W Denman
Director
|
05/20/22 [Form 4]
|